
V. Liana Tsikitis
@tsikitis
Professor @OHSUSurgery; colorectal surgeon; research focused on colorectal cancer; Diversity @OHSU.
ID: 1021496711766716416
https://www.ohsu.edu/providers/vliana-tsikitis-md-mcr-mba-facs-fascrs 23-07-2018 20:46:09
244 Tweet
461 Followers
210 Following




Access, adherence and quality are 🔑. Amazing masterclass on #coloncancer #screening from the one and only Dr David Lieberman at grand rounds. OHSU School of Medicine OHSU Knight Cancer Institute OHSU News American Gastroenterological Association (AGA) ACG ASGE GI Endoscopy


Congratulations to my friend Lorenzo Ferri MD PhD I know ISDS will thrive under your Presidency ! #isw2024kualalumpur International Society of Surgery (ISS/SIC)


Today, the SSAT Greece/Cyprus Chapter hosted their inaugural webinar, 'General Surgery Training in the US and Beyond,' with a global audience. The recorded session will be available shortly at ssat.com/webinar/. Special thanks to Imran Hassan MD for his contribution!




Delighted to host the medical and nursing delegation from the BDMS Hospital System in Thailand 🇹🇭 with V. Liana Tsikitis discussing GI Cancer


Dr. Nima Nabavizadeh OHSU Radiation Medicine presenting @OHSUsurgery Grand Rounds on multicancer early detection studies🩸🧬 🧪 🦀 Great to see OHSU Knight Cancer Institute leading these 🌎 #earlydetection and #precisiononcology efforts



John McCain and I didn’t always agree, but he understood that some values transcended parties. He knew that if we got in the habit of bending the truth to suit political expediency or party orthodoxy, our democracy will not work. John McCain had character. That’s what I think


The world’s largest GI / GI Surgery meeting’s abstract submission is now open. Set in beautiful San Diego by Gas Lamp Quarters. And for HPB folks, The Pancreas Club the day before in La Jolla 20 mins away is the bonus. Get your abstracts in now! Ching-Wei D. Tzeng V. Liana Tsikitis Taylor Riall

💉Neoadjuvant CRT plus tislelizumab in rectal cancer Nature Medicine ➡️%87 pMMR ✅CRT plus tislelizumab after CRT (sequential) vs only CRT pCR: 32.7% and 14.0% (risk ratio 2.332, P=0.019) 👉doi.org/10.1038/s41591… OncoAlert Myriam Chalabi #cancer #oncology #MedX


❓ is can we WW in pts w/ resectable CRLM Hagen Kennecke V. Liana Tsikitis OHSU Knight Cancer Institute #GI25

Wonderful presentation in DC at the American College of Surgeons Leadership & Advocacy Summit by Shan L Kalmeta MD! Oregonians with Medicaid have significant denial rates for ventral hernia repair and abdominal wall reconstruction. Improving access to surgical care is necessary. #OHSUHernia


Fantastic GR by David Larson, MD MBA Mayo Clinic on digital data management & AI in healthcare
